Brain implants without a hole in your skull - Wes Jones of Vonova

Brain implants without a hole in your skull - Wes Jones of Vonova

Wes Jones is the CEO of Vonova, a brain computer interface company that (unlike Neuralink) is enabling access to the brain without drilling a hole in your skull.


Wes joins Brom Rector and Sam Tabone to discuss:


(1:25) - how Wes got into neuro, background as a catheter engineer


(6:30) - how Wes’s parachute malfunction and resulting paralysis made him focused on the brain


(10:30) - how Wes met his cofounder


(14:00) - Wes demonstrating how his device treats chronic subdural hematoma


(18:00) - ancient Peruvian history of brain surgery + the problem of the skull


(22:30) - how does Vonova’s device actually work


(26:00) - Wes’s encounter with Lawrence Livermore National Labs


(28:00) - how Vonova is different than Neuralink


(35:00) - how Vonova could treat chronic pain


(38:00) - could Vonova’s device be used for Neurodegenerative disease


(41:00) - how long does Vonova's device stay implanted?


(43:00) - Wes’s fundraising journey - the challenges of medtech


(47:30) - why wes is excited about drug device combos and a primer on the blood brain barrier + how Vonova could be used for drug delivery


(53:00) - could Vonova’s device be used for brain stimulation


(56:20) - how Vonova’s device could help “solve” the brain + digital twins


(1:00:00) - Wes’s experience as a CEO + his first employee living on his couch for a year


(1:05:00) - does Wes think you need an MBA to start a company (hot take)


(1:08:00) - San Diego


https://www.vonova.io/

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(32)

$HIMS Q2 Results - our take as healthcare venture capitalists

$HIMS Q2 Results - our take as healthcare venture capitalists

Brom Rector and Sam Tabone from XEIA Venture Partners - a VC firm that invests in the future of human health, wellbeing and performance - discuss $HIMS Q2 results and the HIMS business more broadly. W...

5 Elo 20251h 24min

Investing in Psychedelic BioTech [August 2025 webinar replay]

Investing in Psychedelic BioTech [August 2025 webinar replay]

Watch the video recording on YouTube: https://youtu.be/BM6x59oMnKg?si=qF0xDvgUMvU60ctP2025 has been the start of a bull period for psychedelic medicine.​Psychedelic Biotechs like GH Research, Compass ...

30 Heinä 202558min

Compass and ATAI latest news + are Psychedelics BACK in 2025?!

Compass and ATAI latest news + are Psychedelics BACK in 2025?!

The past few years have been rough for psychedelic and shroom stocks, but recent news from ATAI (and Recognify), Compass Pathways and GH Research + positive regulatory tailwinds from RFK and MAHA make...

29 Heinä 202516min

Bryan Johnson's Neuralink competitor - with Kernel CEO Ryan Field

Bryan Johnson's Neuralink competitor - with Kernel CEO Ryan Field

Ryan Field is the CEO of Kernel, a brain-computer interface company founded by Bryan Johnson. Kernel is a cutting edge, non-invasive BCI that uses fNIRS to image the brain. Imagine if getting an MRI w...

22 Heinä 20251h 33min

How to start a VC fund

How to start a VC fund

I interviewed Michael Huseby to learn about his life story and his new book: Fundamentals: Your Friendly Guide to Investment Funds and SyndicationsThis is a great listen for anyone interested in start...

15 Heinä 20251h 20min

Beyond Neuralink - Investing in Brain Computer Interfaces [webinar replay]

Beyond Neuralink - Investing in Brain Computer Interfaces [webinar replay]

Replay of our webinar on investing in brain computer interfaces. Join our upcoming July 30th event on investing in psychedelic biotech: psybio.org

12 Heinä 20251h 9min

Designing Novel Brain Drugs with Xylo Bio

Designing Novel Brain Drugs with Xylo Bio

Xylo is a biotech startup that is using computational methods to design novel brain drugs to treat mental health disorders and neurodegeneration. Many of their drug candidates are inspired by naturall...

8 Heinä 20251h

The BioIndustrial Revolution: Why Peter Thiel and Chris Sacca backed Arye's Biomanufacturing Startup

The BioIndustrial Revolution: Why Peter Thiel and Chris Sacca backed Arye's Biomanufacturing Startup

Arye Lipman is the cofounder of Biosphere, a startup that recently raised millions of dollars from Peter Thiel's Founders Fund and Chris Sacca's Lower Carbon Capital to Unleash Industrial Biomanufactu...

30 Kesä 20251h 20min